hotspot -WSS

hotspot

author：comprehensive 2025-09-06 02:16:25 - browse：333

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

knowledge

WSS

What we’ve learned from the Aduhelm mess

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Vaccine advisory panel ACIP left half staffed by HHS

Vaccine advisory panel ACIP left half staffed by HHS

Caregivers of transplant patients call for more support, training

Wikipedia

hotspot

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Tori Bowie and the unacceptable rates of Black maternal death

Gilead might be held responsible for not developing a drug

Drug repurposing or repositioning? The language matters

Medical mystery: When a cough is not just a cough

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Drug repurposing or repositioning? The language matters

Heart disease and mental health: A look at cardiac psychology

entertainment

As JPM 2024 winds down, some health tech firms project optimism

Medicare Advantage proposed rates disappoint insurers

Gilead might be held responsible for not developing a drug

Heart disease and mental health: A look at cardiac psychology

Vaccine advisory panel ACIP left half staffed by HHS

BioAge raises $170M for combination therapy with Zepbound

hotspot

knowledge

focus

explore